Management consideration in nonpulmonary visceral metastatic seminoma of testis

Journal of Korean Medical Science

Volumn 14, Issue 4, 1999, Pages 431-437

  Park, Dong Soo ^a   Prow, Debra M ^b   Amato, Robert J ^b   Logothetis, Christopher J ^b  

^a CHA University   (South Korea)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Neoplasm metastasis; Seminoma; Testis; Therapeutics

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BONE TUMOR; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SEMINOMA; TESTIS TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0033175689     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.4.431     Document Type: Article

References (17)

1. Samuels ML, Lanzotti VJ, Holoye PY, Boyle E, Smith TL, Johnson DE. Combination chemotherapy in germinal cell tumors. Cancer Treat Rev 1976; 3: 185-204.
2. Ball D, Barrett A, Peckham MJ. The management of metastatic seminoma testis. Cancer 1982; 50: 2289-94.
3. Friedman EL, Garnick MB, Stomper PC, Mauch PM, Harrington DP, Richie JP. Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 1985; 3: 1325-32.
4. Logothetis CJ, Samuel ML, Ogden SL, Dexeus FH, Chong CDK. Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term follow-up in 52 patients. J Urol 1987; 138: 789-94.
5. Motzer RJ, Bosl GJ, Geller NL, Penenberg D, Yagoda A, Golbey R, Whitmore WF, Fair W, Sogani P, Herr H, Morse M, Carcy RW, Vogelzang N. Advanced seminoma: the role of chemotherapy and adjunctive surgery. Ann Intern Med 1988; 108: 513-8.
6. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994; 12: 120-6.
7. Motzer R, Bosl G, Heelan R, Fair W, Whimore W, Sogani P, Herr H, Morse M. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 1987; 5: 1064-70.
8. Schultz SM, Einhorn LH, Conces DJ Jr, Williams SD, Loehrer PJ. Management of postchemotherapy residual mass in patients wth advanced seminoma: Indiana University experience. J Clin Oncol 1989; 7: 1497-503.
9. Amato RJ, Ellerhorst J, Banks M, Logothetis CJ. Carboplatin and ifosfamide and selective consolidation in advanced seminoma. Eur J Cancer 1995; 31A: 2223-8.
10. Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, Bajorin DF, Bosl GJ, Mencel P, Motzer RJ. Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 1996; 14: 454-60.
11. Logothetis CJ. The case for relevant staging of germ cell tumors. Cancer 1990; 65: 709-17.
12. The International Germ Cell Cancer Collaborative Group. international Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603.
13. Samuels ML, Johnson DE, Brown B, Bracken RB, Moran ME, von Eschenbach A. Velban plus continuous infusion bleomycin (VB-3) in stage III advanced testicular cancer: results in 99 patients with a note on high-dose velban and sequential cisplatinum. In: Johnson DE, Samuels ML, eds. Cancer of the genitourinary tract: M.D. Anderson clinical conference on cancer. 23rd. New York: Raven Press, 1979: 159-72.
14. Higby DJ, Wallace HJ Jr, Albert D, Holland JF. Diaminodichloroplatinum in the chemotherapy of testicular tumors. J Urol 1974; 112: 100-4.
15. Duchesne GM, Stenning SP, Aass N, Mead GM, Fossa SD, Oliver RTD, Horwich A, Read G, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook PA. Radiotherapy after chemotherapy for metastatic seminoma - a diminishing role. Eur J Cancer 1997; 33: 829-35.
16. Nichols CR. Ifosfamide in the treatment of germ cell tumors. Semin Oncol 1996; 23: 65-73.
17. Herr HW, Bosl G. Residual mass after chemotherapy for seminoma: changing concepts of management. J Urol 1987; 137: 1234-5.